News Sodium Bicarbonate May Mitigate Calcium Phosphate Stone Risk in CKD By Jody A. Charnow Publish Date April 19, 2021
News Trodelvy Gets Accelerated Approval for Urothelial Cancer By Brian Park, PharmD Publish Date April 14, 2021
News Gemtesa Now Available for Overactive Bladder Treatment By Brian Park, PharmD Publish Date April 12, 2021
News FDA Clears Point-of-Care Test for Chlamydia, Gonorrhea By Diana Ernst, RPh Last Modified Date March 31, 2021
Drugs in the Pipeline Vadadustat NDA Submitted for Anemia Due to Chronic Kidney Disease By Diana Ernst, RPh Publish Date March 30, 2021
News Myrbetriq Approved for Pediatric Neurogenic Detrusor Overactivity By Steve Duffy Publish Date March 29, 2021
Drugs in the Pipeline Kyzatrex Under Review for Primary and Secondary Male Hypogonadism By Brian Park, PharmD Publish Date March 11, 2021
News Tecentriq Indication for Prior-Platinum Treated Bladder Cancer Withdrawn By Brian Park, PharmD Publish Date March 8, 2021
Features Jury Penalizes Physician for Failing to Follow Up on Abnormal Urinalysis By Ann W. Latner, JD Publish Date March 8, 2021
Drugs in the Pipeline FDA to Review Difelikefalin for Chronic Kidney Disease-Associated Pruritus By Brian Park, PharmD Publish Date March 8, 2021
News Imfinzi Indication for Urothelial Carcinoma Withdrawn By Brian Park, PharmD Publish Date February 23, 2021
News Adding Vibegron to BPH Meds Safe, Effective for Overactive Bladder By Natasha Persaud Publish Date February 16, 2021
News Botox Approved for Neurogenic Detrusor Overactivity in Pediatric Patients By Brian Park, PharmD Publish Date February 11, 2021